Running diagnostics

Running diagnostics

Monday, May 28, 2018

Peptic Ulcer Disease

As usual, the following post is available in podcast form at www.medonthego.podbean.com. Feel free to also check out our Facebook page at www.facebook.com/drolimedonthego/. If you enjoy and wish to support our work please visit www.patron.podbean.com/medonthego for more details.

By definition, peptic ulcer disease refers to focal defects in the mucosa of the stomach and duodenum that penetrate the muscularis mucosal layer, resulting in scarring (defects superficial to the muscularis mucosa are erosions and do not cause scarring.

(Quick review of anatomy: the GIT contains four layers. The inner most layer is the mucosa—which includes epithelium, lamina propria, and muscularis mucosa—followed the sub mucosa, muscularis propria, and adventitia.

Helicobacter pylori, previously Campylobacter pylori, is a gram-negative, microaerophilic bacterium found usually in the stomach. It was identified in 1982 by Australian scientists Barry Marshall and Robin Warren, who found that it was present in a person with chronic gastritis and gastric ulcers, conditions not previously believed to have a microbial cause. It is also linked to the development of duodenal ulcers and stomach cancer. More than 50% of the world's population harbor H. pylori in their upper gastrointestinal tract, more common in developing countries. However, over 80% of individuals infected with the bacterium are asymptomatic.)

Etiology

Duodenal
Gastric
H. Pylori
90%
60%
NSAID
7%
35%
Idiopathic
15%
10%
Physiologic (stress-induced)
<3%
<5%
Zollinger-Ellison Syndrome
<1%
<1%

(Another brief review: Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). These tumors, called gastrinomas, secrete large amounts of the hormone gastrin, which causes the stomach to produce too much acid.)

Ulcers not related to H. Pylori or NSAIDs are becoming more commonly recognized; these include CMV, cirrhosis of the liver, COPD, chronic renal failure, ischemic and idiopathic causes. Cigarette smoking has been linked to peptic ulcer disease; smoking not only impairs healing but also increases the risk of ulcers, complications, and death. In contrast to popular belief, alcohol consumption damages the gastric mucosa but does not cause ulcers.

Clinical presentation
·      Dyspepsia
o   Most common presentation
o   Only 5% will have ulcers—most have functional disease
o   Can present with complications
§  Bleeding—most common! 10% The bleeding can be severe if from the gastroduodenal artery
§  Perforation (usually from anterior ulcers) 2%
§  Gastric outlet obstruction 2%
§  Posterior inflammation (penetration) 2% and can cause pancreatitis
·      Duodenal ulcers
o   History alone is very similar to that of functional dyspepsia
o   6 classical features
§  Epigastric pain: may localize to tip of xiphoid
§  Burning sensation
§  Develops 1~3 hours after meals
§  Relieved by eating and antacids
§  Interrupts sleep
§  Periodicity (tends to occur in clusters over a week with subsequent periods of remission)
·      Gastric ulcers
o   More atypical symptoms
§  Dull aching pain, often right after eating.
§  Eating will not relieve pain!
§  Dyspepsia or acid reflux
§  Episodes of nausea
§  A noticeable loss of appetite
§  Unplanned weight loss
o   A BIOPSY REQUIRED to rule out malignancy (whereas duodenal ulcers are rarely malignant.)

Investigations
·      Endoscopy (most accurate)
·      Upper GI series
·      H. Pylori tests
·      Fasting serum gastrin measurement if Zollinger-Ellison syndrome suspected—but most common cause of elevated serum gastrin level is atrophic gastritis.

Treatment
·      Specific management depends on etiology
·      Eradicate H pylori if it is present
·      Stop NSAIDs if possible
·      Start proton-pump inhibitors PPI
o   Inhibits parietal cell H+/K+-ATPase pump which secretes acid
o   Will heal most ulcers even if NSAIDs are continued
o   Other medications such as histamine H2-antagonists are less effective
·      Stop smoking
·      No diet modification required but some people have fewer symptoms if they avoid coffee, alcohol, and spices

Management of bleeding peptic ulcers
·      Endoscopy (OGD) to explore upper GI tract
·      IV pantoprazole continuous drip
·      Evaluate risk of rebleeding/continuous bleeding (most ulcers will stop bleeding spontaneously
o   Clinical risk factors: increased age (>60), bleeding diathesis, history of peptic ulcer disease, comorbid disease, hemodynamically unstable (transfusion required)
o   Endoscopic signs of recurrent bleeding are more predictive than clinical risk factors: active bleeding, visible vessel, clots, red spots
o   If high risk, consider ICU admission



H. Pylori-induced peptic ulceration

Pathophysiology
·      H. Pylori are Gram-negative flagellated rod that resides within the gastric mucosa, causing persistent infection and inflammation.
·      Acid secreted by parietal cells (stimulated by vagal acetylcholine, gastrin, histamine) is necessary for most ulcers
·      No satisfactory theories of how H. pylori causes ulcers, but pattern of colonization correlates with outcome
o   Gastritis only in antrum (15% of patients) and high gastric acid are associated duodenal ulcer and may progress to gastric metaplasia of duodenum where ulcer forms.
o   Gastritis through stomach (“pangastritis”—85% of patients) and low gastric acid are associated with stomach ulcer and cancer.

Epidemiology
·      H. Pylori is found in about 20% of all Canadians
·      Highest prevalence in those raised during the 1930s
·      Infection most commonly acquired in childhood, presumably by fecal-oral route
·      High prevalence in developing countries, particularly in those of low socioeconomic status (poor sanitation and overcrowding)

Outcome
·      Non-erosive gastritis in 100% of patients but asymptomatic
·      Peptic ulcer in 15% of patients
·      Gastric carcinoma and mucosal associated lymphomatous tissue (MALT) lymphoma in 0.5% of patients
·      Most are asymptomatic but still worthwhile eradicating to lower future risk of peptic ulcer/gastric malignancy and prevent spread to others (mostly children <5 years)

Diagnosis
·      Non-invasive
o   Urea breath test
§  90~100% sensitivity
§  89~100% specificity
§  Can be falsely negative when on PPI therapy
o   Serology
§  88~99% sensitivity
§  89~95% specificity
§  Can remain positive after treatment
·      Invasive (requires endoscopy)
o   Histology
§  93~99% sensitivity
§  95~99% specificity
§  Gold standard!
§  Can be falsely negative when on PPI therapy
o   Rapid urease test (on biopsy)
§  89~98% sensitivity
§  93~100% specificity
§  Rapid
o   Microbiology culture
§  98% sensitivity
§  95~100% specificity
§  Research only

Treatment: H. Pylori eradication
·      Triple therapy for 7~14 days
o   PPI bid + amoxicillin 1g bid + clarithromycin 500mg bid
o   Becoming less successful as prevalence of H. pylori clarithromycin-resistance on the rise
·      Quadruple therapy for 10~14 days now recommended
o   PPI bid + bismuth 525mg qid + tetracycline 500mg qid +metronidazole 250mg qid
·      Levofloxacin can replace metronidazole or tetracycline
·      Sequential therapy
o   5 days of PPI bid + amoxicillin 1g bid
o   6~10 days of PPI bid + clarithromycin 500mg bid, tinidazole 500mg bid (generally substitute with metronidazole as tinidazole is not available in Canada)
·      5~15% are resistant to all known therapies

NSAID-induced ulceration

NSAID use causes gastric mucosal petechiae in virtually all erosions in most people and ulcers in some people (25%); erosions can bleed, but usually only ulcers cause significant clinical problems. Most NSAID ulcers are clinically silent—dyspepsia is as common in patients with ulcers as patients without ulcers; NSAID-induced ulcers characteristically present with complications such as bleeding, perforation, and obstruction. NSAIDs more commonly cause gastric ulcers than duodenal ulcers. NSAID use may exacerbate underlying duodenal ulcer disease.

Pathophysiology
·      Direct: erosions/petechiae are due to local effect of drug on gastric mucosa
·      Indirect: systemic NSAID effect (intravenous NSAID causes ulcers, but not erosions due to inhibition of mucosal cyclooxygenase, leading to decreased synthesis of protective prostaglandins, thus leading to ulcers

Risk factors for NSAID-induced peptic ulcer
·      Previous peptic ulcers or upper GI bleeding
·      Age >65
·      High dose of NSAID/multiple NSAIDs being taken
·      Concomitant corticosteroid use
·      Concomitant cardiovascular disease/other significant disease

Management
·      Prophylactic cytoprotective therapy with PPI is recommended if any of the above risk factors exist concomitantly with ASA/NSAID use
·      Lower NSAID dose or stop all together and replace with acetaminophen
·      Combine NSAID with PPI or misoprostol (less effective) in one tablet
·      Enteric coating of aspirin provides minor benefit since this decreases incidence of erosion, not incidence of ulceration

Stress-induced ulceration

Defined as ulceration or erosion in the upper GI tract of ill patients, usually in ICU (the stress is physiologic not psychologic), stress-induced lesions are most commonly in the fundus of the stomach. The pathophysiology is unclear; it likely involves ischemia and may be cause by CNS disease and acid hypersecretion.

Risk factors include:
·      Mechanical ventilation—most important
·      Anti-coagulation
·      Multi-organ failure
·      Septicemia
·      Severe surgery/trauma
·      CNS injury
·      Burns involving more than 35% of body surface

Curling’s ulcer
Cushing’s ulcer
Acute peptic ulcer of the duodenum resulting as a complication from severe burns when reduced plasma volume leads to ischemia and cell necrosis (sloughing) of the gastric mucosa.
Think: BURN from a CURLING iron!
Peptic ulcer produced by elevated intracranial pressure (may be due to stimulation of vagal nuclei secondary to elevated ICP which leads to increased secretion of gastric acid)


Clinical feature is painless upper GI bleeding. Treatment includes prophylaxis with gastric acid suppressants to decrease the risk of upper GI bleeding. PPI most potent but may increase risk of pneumonia; H2 blockers less potent but less likely to cause pneumonia. In active bleeding ulcer the treatment is the same as covered above in peptic ulcer disease but often less successful.

Friday, May 18, 2018

Gastritis

As always, today's post is available in podcast form on www.medonthego.podbean.com and feel free to check out our Facebook page www.facebook.com/drolimedonthego.

Today we discuss another common problem that many people have experienced at one time or another—gastritis! Let’s start with a review of stomach functions:

 Gastritis is defined histologically as inflammation of the stomach mucosa. There are many different causes of gastritis; sometimes one cause can result in different types of gastritis, and sometimes one person can many causes for gastritis.

Updated Sydney Classification of Gastritis (and etiology):
·      Acute gastritis
o   Hemorrhagic/erosive gastritis
§  Alcohol
§  Aspirin/NSAIDs
§  Shock/physiological stress (ICU patients)
o   Helicobacter gastritis
§  H. pylori
·      Chronic gastritis
o   Non-atrophic
§  H. pylori
o   Atrophic
§  H. pylori
§  Dietary
§  Autoimmunity
§  Environmental factors (multi-focal)
o   Chemical
§  NSAIDs
§  Bile
o   Radiation
§  Radiation injury
o   Lymphocytic
§  Celiac disease
§  Drugs
o   Eosinophilic
§  Food allergies
o   Non-infectious granulomatous
§  Crohn’s disease
§  Sarcoidosis
o   Other infectious gastritides
§  Bacteria
§  Viruses
§  Fungi
§  Parasite
§  Tuberculosis
§  Syphilis

In regards to clinical features, non-erosive gastritis is asymptomatic (except in certain causes such as Crohn’s disease) and does not cause pain—making it difficult to diagnose clinically or endoscopically. The diagnosis requires biopsy. Erosive gastritis can cause bleeding (usually without pain; pain only if progresses to ulcers, which is rare) and can be seen endoscopically.

Treatment is determined by etiology specific to the patient. Adjuvant non-pharmacological management includes avoidance of mucosal irritants such as alcohol, NSAIDs, and foods that trigger symptoms.

Case study:
A 76 year-old woman presents to the clinic with generalized weakness and dizziness, so severe that she has had difficulty walking by herself. She reported increasing fatigue and dizziness for the past one week. She denies any chest pain, shortness of breath, palpitations, diarrhea, or black stools.
She does not smoke or drink. She is not on any regular medications but takes some over-the-counter naproxen for joint pain occasionally.
On examination she has pale pink mucosa, orthostatic hypotension, mild epigastric tenderness.

Q: What tests would you order?
A: The following blood tests should be ordered:
·      Complete blood count to assess for anemia, as acute gastritis can cause gastrointestinal bleeding; elevated white cell count may indicate infectious cause
·      Liver and kidney function tests
·      Gallbladder and pancreatic function tests
·      H. pylori serology
Stool occult bloods should be ordered, as well as an endoscopy/colonoscopy to search for a cause of bleeding.

Her hemoglobin is 8 gm/dl and hematocrit 25%. Other routine admission labs are within normal limits. She tested positive for occult stool. Esophogastric endoscopy reveals erosive hemorrhagic gastritis, and a biopsy is performed.

Q: What are the differential diagnoses for this patient?
A: Also consider the following in the differential diagnosis of patients with suspected
•    Acute Complications of Sarcoidosis

•    B-Cell Lymphoma

•    Cholecystitis

•    Crohn’s Disease

•    Gallstones (Cholelithiasis)

•    Gastric Cancer

•    Peptic Ulcer Disease

•    Viral Gastroenteritis
•    Granulomatous gastropathy

Q: What factors may have led to this patient’s bleeding?
A: Although the patient may possibly have H. pylori and associated gastritis, the most common cause of hemorrhagic gastritis in the elderly is medication, especially aspirin and NSAIDs.

Q: Why did this patient not have pain?
A: Elderly patients with NSAID-associated gastric or duodenal damage are often asymptomatic until upper gastrointestinal bleeding or perforation occurs. Bleeding may be gradual, intermittent, and insidious, only showing up on chemical testing.

Q: How should the gastritis be managed?
A: Gastritis induced by NSAIDs without H. pylori infection should be treated with a proton-pump inhibitor or a histamine-2 blocker. NSAID use should be discontinued! If NSAIDs are absolutely necessary, short-acting agents such as ibuprofen, in the lowest possible dose, can be used.

Q: How should her joint pain be managed in the future?

A: Mild joint pain often responds to acetaminophen, and opioid/opioid-like analgesics can be helpful in patients who cannot tolerate NSAIDs. Topical agents such as capsaicin, transdermal lidocaine, and over-the-counter creams containing salicylates or cooling agents like menthol may be useful. Non-pharmacologic therapies such as weight reduction, walking aids, shoe insoles, braces, and prescribed exercises can reduce pain and improve function in some patients. Heat/cold, electrotherapeutics, ultrasound, and acupuncture may also be helpful.

Monday, April 2, 2018

Dyspepsia

Who hasn’t had tummy pains at one time or another? Did you know that the soft drink Pepsi was named Pepsi-Cola after dyspepsia and kola nuts used in the ingredient? It had been designed as a drink that aided digestion. With that in mind, today we talk about this common condition.

Formally defined per Rome III criteria, dyspepsia is one or more of the following symptoms: postprandial fullness, early satiation, epigastric pain, or burning. It can be caused by a multitude of diseases such as esophagitis, GERD, peptic ulcer, drugs, or stomach cancer; but overall functional (idiopathic) disease is most common. In the history, it’s important to note the age, associated symptoms (such as weight loss and vomiting), and drugs (especially NSAIDs); other red flags, raising suspicion of gastric malignancy, include progressive dysphagia, odynophagia, unexplained anemia or iron deficiency, hematemesis, jaundice, palpable abdominal mass or lymphadenopathy, family history of upper GI cancer, or previous gastric surgery.

On physical examination, look for adenopathy, abdominal mass/organomegaly, Carnett’s sign (if pain is due to abdominal wall muscle problem, then the pain will increase during muscle contraction, such as during a sit-up).

The laboratory tests will vary depending on specific associated symptoms and risk factors of the patient, but generally they will include CBC, electrolytes, liver enzymes, glucose, amylase, albumin, calcium, protein electrophoresis, thyroid function tests, and H. pylori serology. Empiric trial of anti-secretory drug therapy, non-invasive testing for H. pylori infection, or endoscopy referral is usually considered while waiting for lab results. BARIUM RADIOGRAPHY IS OUTDATED.

Because dyspepsia is such a broad symptom, let’s go through some particular scenarios—different circumstances will require the medical practitioner to tailor physical examination, laboratory testing, and the management to the needs of different patients.

Case 1: A 36-year-old woman who complains of abdominal discomfort after eating meals.

Q: What is the likely differential diagnosis?
A: The likely differentials are functional dyspepsia and peptic ulcer disease. The patient is too young for gastric outlet obstruction or carcinoma of the stomach.

Q: What information in the history supports the diagnosis?
A: Non-ulcer dyspepsia is a functional disorder often exacerbated by stress. Stressors should be investigated. If the patient also experience early satiety then functional dyspepsia is the most likely diagnosis. If there is persistent vomiting, then obstructive cases or cancer should be considered.

Q: What additional features in the history would you seek to support a particular diagnosis?
A: The patient’s past medical history would definitely shed light on the presentation (such as a history of H. pylori infection and treatment); ethnic background and family history should also be considered—either of which can increase the risk of peptic ulcer disease. Exposure to NSAIDs should be inquired, as well as history of alcohol and cigarette use.

Q: What clinical examination would you perform? Why?
A: A full examination should be performed, looking specifically for lymphadenopathy and epigastric mass. If these don’t exist, then the differentials of functional dyspepsia and peptic ulcer disease can remain most likely.

Q: What investigations would be most helpful? Why?
A: Non-invasive tests for H. pylori would be most helpful, as peptic ulcer disease is strongly associated.

Q: What treatment options are appropriate?
A: Triple therapy for H pylori eradication if the patient tests positive for H pylori. Anti-secretory therapy can be tried. Domperidone may also be prescribed to aid gastric emptying by increasing its motility.

Case 2: A 65-year-old man presents with epigastric pain, vomiting, and weight loss.

Q: What is the likely differential diagnosis?
A: The likely differential diagnoses are pyloric stenosis secondary to H. pylori-associated peptic ulcer disease, carcinoma of the stomach, rare duodenal tumors, polyps, Crohn’s disease, and dysmotility syndrome.

Q: What in the given history supports the diagnosis?
A: Vomiting suggests gastric outlet obstruction. The patient’s age is a risk factor for malignancy.

Q: What additional features in the history would you seek to support a particular diagnosis?
A: The patient’s past medical history and drug history would be very helpful. If the patient is previously using OTC remedies for indigestion, untreated chronic peptic ulcer may be most likely. Duodenal Crohn’s disease and polyps would probably result in recurrent/chronic symptoms. Dysmotility syndrome is rare, except in those with diabetes.

Q: What clinical examination would you perform? Why?
A: A full examination looking for signs of anemia, lymphadenopathy, epigastric mass, and irregular liver edge should be performed.

Q: What investigations would be most helpful? Why?
A: Endoscopy or barium meal should be performed urgently; CT of the upper abdomen should be considered. If these investigations are negative, gastric emptying studies should be performed.

Q: What treatment options are appropriate?

A: If the patient is found to have a benign peptic stricture, endoscopic balloon dilatation should be considered; if the patient has duodenal obstruction, a gastroenterostomy should be performed. If the patient has carcinoma, staging should be performed and surgery considered. If the patient has dysmotility syndrome, Domperidone or erythromycin should be prescribed.

Sunday, April 1, 2018

Med On The Go episode 21: Review of Gastroenterology part 2

Use the link below to listen to the newest episode of Med On The Go. Subscribe to the podcast on Podbean, iTunes, or Google Play to ensure that you'll never miss another episode!

https://medonthego.podbean.com/e/med-on-the-go-episode-21-review-of-gastroenterology-part-2-investigations-and-differential-diagnoses/

Upper GI Bleeds

As always, this blog post is available in podcast form at www.medonthego.podbean.com. You can also find Med On The Go on iTunes and Google ...